Argonautica Private Wealth Management’s Novo Nordisk NVO Stock Holding History

Argonautica Private Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Buy	21,601 +6,936	+47%	+$298K	0.25%	74
2026 Q1	$539K	Buy	14,665 +2,004	+16%	+$95K	0.16%	119
2025 Q4	$644K	Buy	12,661 +3,990	+46%	+$204K	0.19%	102
2025 Q3	$481K	Buy	8,671 +559	+7%	+$32.7K	0.14%	122
2025 Q2	$560K	Sell	8,112 -78	-1%	-$5.31K	0.18%	106
2025 Q1	$569K	Buy	8,190 +726	+10%	+$60K	0.2%	101
2024 Q4	$642K	Sell	7,464 -27	-0.4%	-$2.92K	0.21%	94
2024 Q3	$892K	Buy	7,491 +43	+0.6%	+$5.74K	0.3%	71
2024 Q2	$1.06M	Sell	7,448 -1	-0%	-$133	0.36%	62
2024 Q1	$956K	Buy	7,449 +1,655	+29%	+$197K	0.34%	66
2023 Q4	$599K	Sell	5,794 -18	-0.3%	-$1.78K	0.25%	84
2023 Q3	$529K	Buy	5,812 +24	+0.4%	+$2.11K	0.24%	83
2023 Q2	$468K	Buy	5,788 +922	+19%	+$75.3K	0.21%	92
2023 Q1	$387K	Sell	4,866 -1,142	-19%	-$81K	0.2%	97
2022 Q4	$407K	Buy	+6,008	New	+$352K	0.21%	91

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Argonautica Private Wealth Management's NVO Position: Q2 2026 in Review

Argonautica Private Wealth Management increased its Novo Nordisk (NVO) stake by 47% in Q2 2026, buying an estimated $298K and bringing the position to 21,601 shares worth $1.04M. The position accounts for 0.25% of the portfolio, ranked #74.

Argonautica Private Wealth Management first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.06M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Argonautica Private Wealth Management held 21,601 shares of Novo Nordisk worth $1.04M as of Q2 2026.
Argonautica Private Wealth Management bought 6,936 Novo Nordisk shares in Q2 2026, an estimated $298K.
Novo Nordisk made up 0.25% of Argonautica Private Wealth Management's portfolio in Q2 2026, its #74 holding.
Argonautica Private Wealth Management first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
Argonautica Private Wealth Management's Novo Nordisk position peaked at $1.06M in Q2 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.